Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration

BACKGROUND: Monoclonal antibodies targeting vascular endothelial growth factor (VEGF), such as bevacizumab, are administered intravitreally for the treatment of wet or exudative age-related macular degeneration (ARMD). Systemic use of bevacizumab has been linked to a wide range of renal adverse effe...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Nephropathol
Hoofdauteurs: Khneizer, Gebran, Al-Taee, Ahmad, Bastani, Bahar
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Society of Diabetic Nephropathy Prevention 2017
Onderwerpen:
Case Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5607973/
https://ncbi.nlm.nih.gov/pubmed/28975092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/jnp.2017.23
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items